Firefly Neuroscience Inc (AIFF) FinancialsAIFFFinancialFirefly Neuroscience Inc

Evaluating the bottom line, Firefly Neuroscience Inc maintains a gross margin of 49.22%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -384.05%, while the net margin is -385.99%. These profitability ratios, combined with a Return on Equity (ROE) of -70.52%, provide a clear picture of how effectively AIFF converts its operational activities into shareholder value.

In the context of the broader market, AIFF competes directly with industry leaders such as CTXR and NMTC. With a market capitalization of $16.95M, it holds a significant position in the sector. When comparing efficiency, AIFF's gross margin of 49.22% stands against CTXR's 67.07% and NMTC's 59.94%. Such benchmarking helps identify whether Firefly Neuroscience Inc is trading at a premium or discount relative to its financial performance.

Firefly Neuroscience has shown increasing total revenue, with Q2 2026 revenue at 514,000 USD, up from 299,000 USD in Q2 2025. However, the net income remains negative, with losses decreasing from -4,289,000 USD in Q3 2024 to -2,198,000 USD in Q2 2026, indicating improving but still concerning profitability.